Stanford tests radioactive tracer to map cancer spread
NCT ID NCT04840472
Summary
This early-stage study aims to test the safety of a new radioactive imaging agent (111In-panitumumab) designed to help doctors see if head and neck cancer has spread to nearby lymph nodes. Researchers will compare this new method, given by injection before surgery, to the standard dye method used during surgery. The goal is to see if the new approach is safe and if it can more accurately identify which lymph nodes contain cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.